OVERALL SURVIVAL (OS) WITH CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) VERSUS STANDARD OF CARE (SOC) IN LENALIDOMIDE (LEN)-REFRACTORY MULTIPLE MYELOMA (MM): PHASE 3 CARTITUDE-4 STUDY UPDATE
Por:
Leleu, X, San-Miguel, J, Mateos, MV, Dhakal, B, Touzeau, C, Van de Donk, NWCJ, Sidana, S, Oriol, A, Cohen, YC, Harrison, SJ, Einsele, H, Corradini, P, Chen, D, Li, Q, Li, K, Slaughter, A, Lonardi, C, Benachour, N, Vogel, M, Lendvai, N, Koneru, M, Patel, N, Florendo, E, Ho, PJ and Popat, R
Publicada:
1 abr 2025
Resumen:
Filiaciones:
Leleu, X:
CHU Poitiers, Poitiers, France
San-Miguel, J:
Clin Univ Navarra, Canc Ctr, CIMA, IDISNA, Pamplona, Spain
Mateos, MV:
Univ Hosp Salamanca, IBSAL, CIC, CIBERONC, Salamanca, Spain
Dhakal, B:
Med Coll Wisconsin, Milwaukee, WI USA
Touzeau, C:
Ctr Hosp Univ Nantes, Nantes, France
Van de Donk, NWCJ:
Vrije Univ Amsterdam, Med Ctr, Amsterdam Univ, Amsterdam, Netherlands
Sidana, S:
Stanford Univ, Sch Med, Stanford, CA USA
:
Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
Cohen, YC:
Tel Aviv Univ, Tel Aviv Sourasky Ichilov Med Ctr, Tel Aviv, Israel
Harrison, SJ:
Melbourne & Royal Melbourne Hosp, Melbourne, Vic, Australia
Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
Univ Melbourne, Melbourne, Vic, Australia
Einsele, H:
Univ Klinikum Wurzburg, Wurzburg, Germany
Corradini, P:
Univ Milan, Fdn IRCCS Ist Nazl Tumori Milano, Milan, Italy
Chen, D:
Janssen Res & Dev, Beijing, Peoples R China
Li, Q:
Janssen Res & Dev, Raritan, NJ USA
Li, K:
Janssen Res & Dev, Raritan, NJ USA
Slaughter, A:
Cilag GmbH Int, Beijing, Peoples R China
Lonardi, C:
Janssen Res & Dev, Buenos Aires, DF, Argentina
Benachour, N:
Janssen Res & Dev, Beerse, Belgium
Vogel, M:
Janssen Res & Dev, Berlin, Germany
Lendvai, N:
Janssen Res & Dev, Raritan, NJ USA
Koneru, M:
Legend Biotech USA Inc, Somerset, NJ USA
Patel, N:
Legend Biotech USA Inc, Somerset, NJ USA
Florendo, E:
Legend Biotech USA Inc, Somerset, NJ USA
Ho, PJ:
Royal Prince Alfred Hosp, Sydney, NSW, Australia
Univ Sydney, Sydney, NSW, Australia
Popat, R:
Univ Coll London Hosp NHS Fdn Trust, London, England
|